Stratview Research has published a new report on the Cardiac Mapping Market, segmented by Product Type (Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems), by Indication Type (Atrial Fibrillation, Atrial Flutter, AVNRT, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World). This report provides critical insights into the market dynamics and enables strategic decision-making for the existing and new market players.
Market Highlights
The cardiac mapping market was estimated at USD 1.86 billion in 2022 and is likely to grow at a CAGR of 8.76% during 2023-2028 to reach USD 3.09 billion in 2028.
Cardiac mapping is the process of identifying the temporal and spatial distribution of myocardial electrical potentials during a particular heart rhythm. It covers several modes of mapping such as body surface, endocardial, and epicardial mapping. The global cardiac mapping market is categorized on the basis of product type into contact mapping systems and non-contact mapping systems. Based on the indication type, it is categorized into atrial fibrillation, atrial flutter, and AVNRT.
Market Dynamics
The prime factors that are driving the cardiac mapping market are-
- Growing investments, funds, and grants.
- Increasing incidence of target diseases.
- Growth in the geriatric population.
Segmentation –
This report studies the Cardiac Mapping Market and has segmented the market in a few ways, keeping in mind the concentration of all the stakeholders across the value chain. Following are the ways in which the market has been segmented in the report:
Based on the product type, the market is segmented as contact cardiac mapping systems and non-contact cardiac mapping systems. Contact cardiac mapping system is expected to witness higher growth during the forecast period. Contact cardiac mapping system further includes electroanatomical mapping, basket catheter mapping, and traditional endocardial mapping. Major advantages of contact cardiac mapping systems such as detection of the precise locations of mapping and ablation catheters in a three-dimensional environment, also with multi-electrode basket catheters, recording just a few beats might be enough to uncover the arrhythmia circuit are the factors increasing its adoption.
Based on the indication type, the market is segmented as atrial fibrillation, atrial flutter, AVNRT, and other arrhythmias. Atrial fibrillation holds the largest share of the market and is also expected to witness healthy growth during the forecast period.
In terms of regions, North America is estimated to be the largest market for cardiac mapping during the forecast period. The increase in the approval rate of mapping systems and clinical trials validating cardiac mapping systems in the USA, the high incidence of CVDs, the growing focus of government organizations on providing funding for research, and the increasing geriatric population in Canada are the major factors driving the North American market. Europe and Asia-Pacific are also expected to offer lucrative opportunities during the forecast period.
Following are the key players in the Cardiac Mapping Market:
- Biosense Webster,
- Abbott, and Boston Scientific Corporation,
- Medtronic,
- MicroPort Scientific Corporation,
- EP Solutions SA,
- Acutus Medical,
- Koninklijke Philips N.V. (Royal Philips),
- Lepu Medical,
- BIOTRONIK,
- AngioDynamics,
- BioSig Technologies,
- APN Health,
- CoreMap,
- Kardium,
- Catheter Precision,
- Epmap-System.
About Stratview Research-
Stratview Research is a global market intelligence firm having a strong team of industry veterans and research analysts. Stratview Research has been serving multiple clients across a wide array of industries. Our services cover a broad spectrum of industries including but not limited to Energy Chemicals, Advanced Materials, Automotive, and Aerospace. At Stratview, we believe in building long term relations with our clients.
Connect with our team here–
https://www.stratviewresearch.com/contact
Or
Call us @: +1-313-307-4176
